Similar Papers

Paper Title
Journal
Date
Author
Abstract OT-03-09: Trastuzumab deruxtecan (T-DXd; DS-8201) vs investigator’s choice of chemotherapy in patients with hormone receptor-positive (HR+), HER2 low metastatic breast cancer whose disease has progressed on endocrine therapy in the metastatic setting: A randomized, global phase 3 trial (DESTINY-Breast06)
Aditya Bardia ... Kan Yonemori
Cancer Research | VOL. 81
Aditya Bardia, et. al.Aditya Bardia ... Kan Yonemori
15 Feb 2021
Expanding the treatment options for HER2-low metastatic breast cancer: Experience with trastuzumab deruxtecan in aggressive luminal HER2-low breast cancer
E V Lubennikova ... E V Artamonova
Meditsinskiy sovet = Medical Council | VOL. -
E V Lubennikova, et. al.E V Lubennikova ... E V Artamonova
24 Jul 2024
Modeling the impact of using trastuzumab deruxtecan in patients with breast cancer on reducing cancer mortality in Russia
N A Avxentyev ... A S Makarov
Tumors of female reproductive system | VOL. 20
N A Avxentyev, et. al.N A Avxentyev ... A S Makarov
26 Jul 2024
Cost-effectiveness of trastuzumab deruxtecan in HER2 low metastatic breast cancer.
James Dickerson ... Jeremy D Goldhaber-Fiebert
Journal of Clinical Oncology | VOL. 41
James Dickerson, et. al.James Dickerson ... Jeremy D Goldhaber-Fiebert
01 Jun 2023
View more papers

More From: Annals of Case Reports

Paper Title
Journal
Date
Author
Parapelvic Cyst Causing Hydronephrosis Managed by Sclerotherapy: A Case Report
-
Annals of Case Reports | VOL. -
--
27 Jan 2025
Case Report: Cutaneous Myopericytoma on the Elbow August 2024
-
Annals of Case Reports | VOL. -
--
20 Jan 2025
Case Report: Pentoxifylline Use for Inhibition of Significantly Increased Inflammatory Response in Preterm Infant with Diagnosed Late-Onset Sepsis
-
Annals of Case Reports | VOL. -
--
15 Jan 2025
Eosinophilia with Respiratory Symptoms and Rash: A Diagnostic Challenge
-
Annals of Case Reports | VOL. -
--
13 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.